Trillium Asset Management, LLC Nevro Corp Transaction History

Trillium Asset Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 10, 2020	SELL	$76.41 - $117.54 $845,553 - $1.3 Million	-11,066 Closed	0 $0
Q3 2019 Nov 06, 2019	SELL	$61.52 - $91.1 $861 - $1,275	-14 Reduced 0.13%	11,066 $951,000
Q2 2019 Aug 08, 2019	BUY	$58.04 - $66.99 $74,755 - $86,283	1,288 Added 13.15%	11,080 $718,000
Q1 2019 May 06, 2019	BUY	$35.52 - $62.62 $26,107 - $46,025	735 Added 8.12%	9,792 $612,000
Q4 2018 Feb 08, 2019	BUY	$35.43 - $56.29 $1,594 - $2,533	45 Added 0.5%	9,057 $352,000
Q3 2018 Nov 09, 2018	BUY	$44.22 - $75.47 $5,925 - $10,112	134 Added 1.51%	9,012 $514,000
Q2 2018 Aug 01, 2018	BUY	$72.38 - $92.5 $11,725 - $14,985	162 Added 1.86%	8,878 $709,000
Q1 2018 May 09, 2018	BUY	$69.46 - $88.57 $4,862 - $6,199	70 Added 0.81%	8,716 $755,000
Q4 2017 Feb 01, 2018	BUY	$65.94 - $93.31 $6,396 - $9,051	97 Added 1.13%	8,646 $597,000
Q3 2017 Nov 02, 2017	BUY	$80.87 - $91.08 $691,357 - $778,642	8,549	8,549 $777,000

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $133M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Trillium Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Trillium Asset Management, LLC with notifications on news.